Cargando…

Effect of Phosphatidylserine and Cholesterol on Membrane-mediated Fibril Formation by the N-terminal Amyloidogenic Fragment of Apolipoprotein A-I

Here, we examined the effects of phosphatidylserine (PS) and cholesterol on the fibril-forming properties of the N-terminal 1‒83 fragment of an amyloidogenic G26R variant of apoA-I bound to small unilamellar vesicles. A thioflavin T fluorescence assay together with microscopic observations showed th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mizuguchi, Chiharu, Nakamura, Mitsuki, Kurimitsu, Naoko, Ohgita, Takashi, Nishitsuji, Kazuchika, Baba, Teruhiko, Shigenaga, Akira, Shimanouchi, Toshinori, Okuhira, Keiichiro, Otaka, Akira, Saito, Hiroyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882889/ https://www.ncbi.nlm.nih.gov/pubmed/29615818 http://dx.doi.org/10.1038/s41598-018-23920-3

Ejemplares similares

Amyloidogenic 60–71 deletion/ValThr insertion mutation of apolipoprotein A-I generates a new aggregation-prone segment that promotes nucleation through entropic effects
por: Namba, Norihiro, et al.
Publicado: (2023)

Iowa Mutant Apolipoprotein A-I (ApoA-I(Iowa)) Fibrils Target Lysosomes
por: Kameyama, Hirokazu, et al.
Publicado: (2016)

Immunochemical Approach for Monitoring of Structural Transition of ApoA-I upon HDL Formation Using Novel Monoclonal Antibodies
por: Kimura, Hitoshi, et al.
Publicado: (2017)

Structural flexibility of apolipoprotein E-derived arginine-rich peptides improves their cell penetration capability
por: Takechi-Haraya, Yuki, et al.
Publicado: (2023)

Mechanisms of enhanced aggregation and fibril formation of Parkinson’s disease-related variants of α-synuclein
por: Ohgita, Takashi, et al.
Publicado: (2022)

Effect of hydrophobic moment on membrane interaction and cell penetration of apolipoprotein E-derived arginine-rich amphipathic α-helical peptides
por: Takechi-Haraya, Yuki, et al.
Publicado: (2022)

Intramolecular interaction kinetically regulates fibril formation by human and mouse α-synuclein
por: Ohgita, Takashi, et al.
Publicado: (2023)

Design and Synthesis of 6‐O‐Phosphorylated Heparan Sulfate Oligosaccharides to Inhibit Amyloid β Aggregation
por: Uchimura, Kenji, et al.
Publicado: (2022)

The Role of Cholesterol in Amyloidogenic Substrate Binding to the γ-Secretase Complex
por: Orzeł, Urszula, et al.
Publicado: (2021)

Effect of the amyloidogenic L75P apolipoprotein A-I variant on HDL subpopulations
por: Gomaraschi, Monica, et al.
Publicado: (2011)

Human Apolipoprotein A-I Natural Variants: Molecular Mechanisms Underlying Amyloidogenic Propensity
por: Ramella, Nahuel A., et al.
Publicado: (2012)

Probing the Structure–Function relationship and amyloidogenic propensities in natural variants of apolipoprotein A-I
por: Ma'arfi, Farah, et al.
Publicado: (2020)

Light-induced propulsion of a giant liposome driven by peptide nanofibre growth
por: Inaba, Hiroshi, et al.
Publicado: (2018)

ACAT1-associated Late Endosomes/Lysosomes Significantly Improve Impaired Intracellular Cholesterol Metabolism and the Survival of Niemann-Pick Type C Mice
por: Kamikawa, Masashi, et al.
Publicado: (2014)

Amyloidogenic variant of apolipoprotein A-I elicits cellular stress by attenuating the protective activity of angiogenin
por: Del Giudice, R, et al.
Publicado: (2014)

Amyloidogenic Propensity of a Natural Variant of Human Apolipoprotein A-I: Stability and Interaction with Ligands
por: Rosú, Silvana A., et al.
Publicado: (2015)

Influence of Domain Stability on the Properties of Human Apolipoprotein E3 and E4 and Mouse Apolipoprotein E
por: Nguyen, David, et al.
Publicado: (2014)

Production of Cloned Miniature Pigs Expressing High Levels of Human Apolipoprotein(a) in Plasma
por: Ozawa, Masayuki, et al.
Publicado: (2015)

Enzymatic remodeling of heparan sulfate: a therapeutic strategy for systemic and localized amyloidoses?
por: Nishitsuji, Kazuchika, et al.
Publicado: (2016)

Development of a novel tocopheryl ester for suppression of lipid accumulation without cytotoxicity by optimization of dicarboxylic ester moiety
por: Yamasaki, Misaki, et al.
Publicado: (2022)

Interactions of Apolipoprotein A-I with High-Density Lipoprotein Particles
por: Nguyen, David, et al.
Publicado: (2013)

CXCL14 Acts as a Specific Carrier of CpG DNA into Dendritic Cells and Activates Toll-like Receptor 9-mediated Adaptive Immunity
por: Tanegashima, Kosuke, et al.
Publicado: (2017)

Increasing Membrane Cholesterol Level Increases the Amyloidogenic Peptide by Enhancing the Expression of Phospholipase C
por: Chun, Yoon Sun, et al.
Publicado: (2013)

Interplay between Asters/GRAMD1s and phosphatidylserine in intermembrane transport of LDL cholesterol
por: Trinh, Michael N., et al.
Publicado: (2022)

TMEM41B and VMP1 are scramblases and regulate the distribution of cholesterol and phosphatidylserine
por: Li, Yang Emma, et al.
Publicado: (2021)

Standardization of Apolipoprotein B, LDL‐Cholesterol, and Non‐HDL‐Cholesterol
por: Contois, John H., et al.
Publicado: (2023)

Development of a Chemical Methodology for the Preparation of Peptide Thioesters Applicable to Naturally Occurring Peptides Using a Sequential Quadruple Acyl Transfer System
por: Tsuda, Yusuke, et al.
Publicado: (2015)

Tocotrienol Affects Oxidative Stress, Cholesterol Homeostasis and the Amyloidogenic Pathway in Neuroblastoma Cells: Consequences for Alzheimer’s Disease
por: Grimm, Marcus O. W., et al.
Publicado: (2016)

Interaction of two antitumor peptides with membrane lipids – Influence of phosphatidylserine and cholesterol on specificity for melanoma cells
por: Wodlej, Christina, et al.
Publicado: (2019)

Last step in the path of LDL cholesterol from lysosome to plasma membrane to ER is governed by phosphatidylserine
por: Trinh, Michael N., et al.
Publicado: (2020)

Graph-Based Analyses of Dynamic Water-Mediated Hydrogen-Bond Networks in Phosphatidylserine: Cholesterol Membranes
por: Jain, Honey, et al.
Publicado: (2023)

Exploiting heterogeneous features to improve in silico prediction of peptide status – amyloidogenic or non-amyloidogenic
por: Nair, Smitha Sunil Kumaran, et al.
Publicado: (2011)

Membranous Nephropathy-Like Apolipoprotein E Deposition Disease with Apolipoprotein E Toyonaka (Ser197Cys) and a Homozygous Apolipoprotein E2/2
por: Fukunaga, Megumu, et al.
Publicado: (2018)

The apolipoprotein E polymorphism and the cholesterol-raising effect of coffee
por: Strandhagen, Elisabeth, et al.
Publicado: (2004)

Cholesterol Efflux Capacity of Apolipoprotein A-I Varies with the Extent of Differentiation and Foam Cell Formation of THP-1 Cells
por: Yano, Kouji, et al.
Publicado: (2016)

Amyloidogenic determinants are usually not buried
por: Frousios, Kimon K, et al.
Publicado: (2009)

The Diagnostic Potential of Amyloidogenic Proteins
por: Jin, Yiyun, et al.
Publicado: (2021)

Structure dynamics of ApoA-I amyloidogenic variants in small HDL increase their ability to mediate cholesterol efflux
por: Nilsson, Oktawia, et al.
Publicado: (2020)

The joint effects of apolipoprotein B, apolipoprotein A(1), LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls†
por: Parish, Sarah, et al.
Publicado: (2009)

Phosphatidylserine synthase 2 and phosphatidylserine decarboxylase are essential for aminophospholipid synthesis in T rypanosoma brucei
por: Farine, Luce, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pfsht39hc1ukg02100j7eondvj